Article
Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 Mar 2015
Sánchez-Mora Cristina, Ramos-Quiroga Josep A, Bosch Rosa, Corrales Montse, Garcia-Martínez Iris, Nogueira Mariana, Pagerols Mireia, Palomar Gloria, Richarte Vanesa, Vidal Raquel, Arias-Vasquez Alejandro, Bustamante Mariona, Forns Joan, Gross-Lesch Silke, Guxens Monica, Hinney Anke, Hoogman Martine, Jacob Christian, Jacobsen Kaya K, Kan Cornelis C, Kiemeney Lambertus, Kittel-Schneider Sarah, Klein Marieke, Onnink Marten, Rivero Olga, Zayats Tetyana, Buitelaar Jan, Faraone Stephen V, Franke Barbara, Haavik Jan, Johansson Stefan, Lesch Klaus-Peter, Reif Andreas, Sunyer Jordi, Bayés Mònica, Casas Miguel, Cormand Bru, Ribasés Marta
Abstract excerpt
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with high heritability. At least 30% of patients diagnosed in childhood continue to suffer from ADHD during adulthood and genetic risk factors may play an essential role in the persistence of the disorder throughout lifespan. To date, genome-wide association studies (GWAS) of ADHD have been completed in seven independent datasets,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.